A Translational Study Investigating PD-L1 Expression After Radiotherapy for Non-small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

January 3, 2019

Primary Completion Date

March 18, 2020

Study Completion Date

March 18, 2020

Conditions
Non-Small Cell Lung Cancer
Interventions
PROCEDURE

Biopsy and blood samples

"Archival tumour biopsies will be analysed for baseline PD-L1 expression. Some participants will have a biopsy before radiotherapy if the archival biopsy is not suitable.~Participants will be required to undergo an additional mandatory biopsy of the irradiated site during the second week. Patients must have completed at least 1 week of the planned treatment before taking the biopsy.~Participants will also be asked for consent to donate 50ml blood pre biopsy (at baseline and week 2) and at the end of radiotherapy; as well as 10ml blood before #2 radiotherapy and weekly throughout treatment."

Trial Locations (3)

LS9 7TF

St. James's Univerisity Hospital, Leeds

NW1 2BU

University College Hospital, London

M20 4BX

The Christie NHS Foundation Trust, Manchester

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

The Christie NHS Foundation Trust

OTHER